News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,605 Results
Type
Article (41986)
Company Profile (252)
Press Release (671367)
Multimedia
Podcasts (53)
Webinars (12)
Section
Business (208499)
Career Advice (2103)
Deals (35906)
Drug Delivery (100)
Drug Development (82177)
Employer Resources (176)
FDA (16367)
Job Trends (15087)
News (351642)
Policy (33132)
Tag
Academia (2643)
Accelerated approval (5)
Adcomms (25)
Allergies (85)
Alliances (50418)
ALS (89)
Alzheimer's disease (1396)
Antibody-drug conjugate (ADC) (129)
Approvals (16370)
Artificial intelligence (259)
Autoimmune disease (22)
Automation (16)
Bankruptcy (364)
Best Places to Work (11780)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (177)
Bladder cancer (78)
Brain cancer (28)
Breast cancer (281)
Cancer (2286)
Cardiovascular disease (175)
Career advice (1761)
Career pathing (32)
CAR-T (152)
Cell therapy (432)
Cervical cancer (19)
Clinical research (66831)
Collaboration (845)
Company closure (1)
Compensation (533)
Complete response letters (19)
COVID-19 (2620)
CRISPR (41)
C-suite (251)
Cystic fibrosis (100)
Data (2220)
Decentralized trials (2)
Denatured (21)
Depression (44)
Diabetes (276)
Diagnostics (6500)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (123)
Drug pricing (104)
Drug shortages (25)
Duchenne muscular dystrophy (94)
Earnings (88426)
Editorial (38)
Employer branding (21)
Employer resources (149)
Events (115090)
Executive appointments (735)
FDA (17640)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (758)
Gene editing (105)
Generative AI (20)
Gene therapy (309)
GLP-1 (720)
Government (4509)
Grass and pollen (4)
Guidances (67)
Healthcare (19128)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (29)
Infectious disease (2764)
Inflammatory bowel disease (140)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (324)
IPO (16706)
IRA (40)
Job creations (3722)
Job search strategy (1498)
Kidney cancer (10)
Labor market (38)
Layoffs (478)
Leadership (20)
Legal (8041)
Liver cancer (76)
Lung cancer (329)
Lymphoma (154)
Machine learning (7)
Management (60)
Manufacturing (310)
MASH (67)
Medical device (13625)
Medtech (13630)
Mergers & acquisitions (19748)
Metabolic disorders (695)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (90)
Neuropsychiatric disorders (27)
Neuroscience (1939)
NextGen: Class of 2025 (6622)
Non-profit (4589)
Now hiring (39)
Obesity (370)
Opinion (214)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (85)
Parkinson's disease (151)
Partnered (21)
Patents (233)
Patient recruitment (113)
Peanut (46)
People (58599)
Pharmaceutical (66)
Pharmacy benefit managers (18)
Phase I (20807)
Phase II (29406)
Phase III (21920)
Pipeline (1208)
Policy (139)
Postmarket research (2649)
Preclinical (8900)
Press Release (64)
Prostate cancer (107)
Psychedelics (32)
Radiopharmaceuticals (252)
Rare diseases (385)
Real estate (6055)
Recruiting (66)
Regulatory (22684)
Reports (46)
Research institute (2389)
Resumes & cover letters (358)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (71)
Series A (131)
Series B (84)
Service/supplier (11)
Sickle cell disease (53)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (30)
Startups (3635)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (41)
The Weekly (30)
Vaccines (698)
Venture capitalists (41)
Weight loss (241)
Women's health (37)
Worklife (17)
Date
Today (97)
Last 7 days (902)
Last 30 days (2640)
Last 365 days (32987)
2025 (10842)
2024 (35538)
2023 (40490)
2022 (51679)
2021 (56308)
2020 (54768)
2019 (47463)
2018 (35744)
2017 (32835)
2016 (32307)
2015 (38447)
2014 (32134)
2013 (27108)
2012 (29403)
2011 (30041)
2010 (28132)
Location
Africa (764)
Alabama (53)
Alaska (7)
Arizona (236)
Arkansas (13)
Asia (39363)
Australia (6496)
California (6168)
Canada (2022)
China (531)
Colorado (266)
Connecticut (276)
Delaware (149)
Europe (85737)
Florida (913)
Georgia (206)
Idaho (57)
Illinois (542)
India (26)
Indiana (311)
Iowa (11)
Japan (164)
Kansas (105)
Kentucky (24)
Louisiana (10)
Maine (70)
Maryland (906)
Massachusetts (4601)
Michigan (226)
Minnesota (395)
Mississippi (2)
Missouri (86)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1737)
New Mexico (28)
New York (1754)
North Carolina (1005)
North Dakota (8)
Northern California (2690)
Ohio (207)
Oklahoma (14)
Oregon (34)
Pennsylvania (1380)
Puerto Rico (12)
Rhode Island (33)
South America (1144)
South Carolina (23)
South Dakota (1)
Southern California (2317)
Tennessee (101)
Texas (913)
United States (23324)
Utah (183)
Virginia (147)
Washington D.C. (64)
Washington State (553)
West Virginia (3)
Wisconsin (59)
713,605 Results for "international isotopes inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
International Isotopes Inc. Announces Fiscal Results for Fiscal Year 2023
International Isotopes Inc. announces its financial results for the twelve-month periods ended December 31, 2023.
April 1, 2024
·
6 min read
Business
International Isotopes Inc. Announces Fiscal Results for the Third Quarter and First Nine Months of 2023
International Isotopes Inc. announces its financial results for the three- and nine-month periods ended September 30, 2023.
November 14, 2023
·
6 min read
Press Releases
Telix Adds Lead-212 Isotope Production Capability
March 13, 2025
·
6 min read
Press Releases
Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology
April 18, 2025
·
6 min read
Business
International Isotopes Inc. Announces Fiscal Results for the Second Quarter and First Six Months of 2023
International Isotopes Inc. announces its financial results for the three- and six-month periods ended June 30, 2023.
August 14, 2023
·
7 min read
Business
Cambridge Isotope Laboratories, Inc. (CIL) Announces Relocation of Corporate Headquarters and Expansion of Research & Development and cGMP Production
Cambridge Isotope Laboratories, Inc., the world leader in stable isotope chemistry and the separation of carbon-13, has announced it will be relocating and expanding its corporate headquarters to newly purchased space in Tewksbury, MA, to advance the operations and growth of the company.
March 15, 2024
·
2 min read
Business
International Isotopes Inc. Announces Financial Results for the First Quarter 2023
International Isotopes Inc. is pleased to announce its financial results for the three months ended March 31, 2023.
May 16, 2023
·
5 min read
Deals
Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform
Telix Pharmaceuticals Limited announces it has entered into an agreement to acquire radioisotope production technology firm ARTMS Inc., its advanced cyclotron-based isotope production platform, manufacturing plant and stockpile of ultra-pure rare metals required for consumable target production.
March 4, 2024
·
11 min read
Genetown
Cambridge Isotope Laboratories (CIL) Shows Long-Term Commitment to Xenia, Ohio, Facility With New Land Purchase
Cambridge Isotope Laboratories, Inc. has acquired an additional 14.8 acres of land at its Cambridge Isotope Separations Xenia, Ohio location.
April 25, 2024
·
2 min read
Press Releases
Cambridge Isotope Laboratories, Inc. Expands 13C Production Capacity With North Star Project
September 6, 2024
·
2 min read
1 of 71,361
Next
